Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Asclemed USA, Inc. | 76420-240 | INTRA-ARTICULAR, INTRAMUSCULAR, INTRALESIONAL | 3 mg in 1 mL | 10/12/2022 | |
| American Regent, Inc. | 0517-0799 | INTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR | 3 mg in 1 mL | 8/19/2019 | |
| Asclemed USA, Inc. | 76420-007 | INTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR | 3 mg in 1 mL | 10/12/2022 | |
| Advanced Rx Pharmacy of Tennessee, LLC | 80425-0347 | INTRA-ARTICULAR, INTRAMUSCULAR, INTRALESIONAL | 3 mg in 1 mL | 7/26/2023 | |
| American Regent, Inc. | 0517-0791 | INTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR | 3 mg in 1 mL | 8/19/2019 | |
| Organon LLC | 78206-118 | INTRAMUSCULAR, INTRA-ARTICULAR, SOFT TISSUE, INTRALESIONAL | 3 mg in 1 mL | 3/4/2024 | |
| American Regent, Inc. | 0517-0720 | INTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR | 3 mg in 1 mL | 6/5/2020 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| CELESTONE CHRONODOSE betamethasone 5.7 mg/1 mL (as acetate and sodium phosphate) injection ampoule | 18777 | Medicine | A | 10/8/1991 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| CELESTONE SOLUSPAN | organon canada inc. | 00028096 | Suspension - Intra-Articular
,
Intramuscular
,
Intradermal
,
Intrabursal | 3 MG / ML | 12/31/1965 |
| BETAJECT | 02237835 | Suspension - Intralesional
,
Intra-Articular
,
Intramuscular | 3 MG / ML | 7/2/1998 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.